Did Peter Meijer sell Vertex Pharmaceuticals stock?

Common questions

Did Peter Meijer sell Vertex Pharmaceuticals stock?

Yes. Peter Meijer disclosed 1 sale of Vertex Pharmaceuticals (VRTX) stock on Jan 28, 2021, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.

How big were Peter Meijer's Vertex Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.

Did Peter Meijer make these Vertex Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Peter Meijer still own Vertex Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Peter Meijer report these trades?

The latest filing is dated Feb 23, 2021. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.